• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载药三甲基壳聚糖-聚乳酸-羟基乙酸共聚物纳米粒递药系统治疗脑疾病的研究进展

Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain.

机构信息

Department of Pharmaceutics, Shenyang Pharmaceutical University, Liaoning, China.

出版信息

Biomaterials. 2010 Feb;31(5):908-15. doi: 10.1016/j.biomaterials.2009.09.104. Epub 2009 Oct 22.

DOI:10.1016/j.biomaterials.2009.09.104
PMID:19853292
Abstract

Trimethylated chitosan (TMC) surface-modified poly(d,l-lactide-co-glycolide) (PLGA) nanoparticles (TMC/PLGA-NP) were synthesized as a drug carrier for brain delivery. TMC was covalently coupled to the surface of PLGA nanoparticles (PLGA-NP) via a carbodiimide-mediated link. The zeta potential of TMC/PLGA-NP was about 20mV with a mean diameter around 150nm. 6-coumarin loaded PLGA-NP and TMC/PLGA-NP were injected into the caudal vein of mice, and fluorescent microscopy of brain sections showed a higher accumulation of TMC/PLGA-NP in the cortex, paracoele, the third ventricle and choroid plexus epithelium, while no brain uptake of PLGA-NP was observed. There was no pronounced difference in cell viability between TMC/PLGA-NP and PLGA-NP as shown by MTT assay. Behavioral testing showed that the injection of coenzyme Q(10) loaded TMC/PLGA-NP greatly improved memory impairment, restoring it to a normal level, but the efficacy was slight for loaded PLGA-NP, without TMC conjugation. The senile plaque and biochemical parameter tests confirmed the brain-targeted effects of TMC/PLGA-NP. These experiments show that TMC surface-modified nanoparticles are able to cross the blood-brain barrier and appear to be a promising brain drug delivery carrier with low toxicity.

摘要

三甲基壳聚糖(TMC)表面修饰的聚(D,L-乳酸-共-乙醇酸)(PLGA)纳米粒子(TMC/PLGA-NP)被合成作为一种用于脑内递送的药物载体。TMC 通过碳二亚胺介导的键合共价偶联到 PLGA 纳米粒子(PLGA-NP)的表面。TMC/PLGA-NP 的 ζ 电位约为 20mV,平均直径约为 150nm。6-香豆素负载的 PLGA-NP 和 TMC/PLGA-NP 被注入小鼠尾静脉,脑切片的荧光显微镜显示 TMC/PLGA-NP 在皮质、旁脑室、第三脑室和脉络丛上皮中的积累更高,而没有观察到 PLGA-NP 的脑摄取。MTT 测定显示 TMC/PLGA-NP 和 PLGA-NP 之间的细胞活力没有明显差异。行为测试表明,辅酶 Q(10)负载的 TMC/PLGA-NP 的注射极大地改善了记忆障碍,使其恢复到正常水平,但负载 PLGA-NP 的效果轻微,没有 TMC 缀合。老年斑和生化参数测试证实了 TMC/PLGA-NP 的脑靶向作用。这些实验表明,TMC 表面修饰的纳米粒子能够穿过血脑屏障,并且似乎是一种具有低毒性的有前途的脑内药物递送载体。

相似文献

1
Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain.载药三甲基壳聚糖-聚乳酸-羟基乙酸共聚物纳米粒递药系统治疗脑疾病的研究进展
Biomaterials. 2010 Feb;31(5):908-15. doi: 10.1016/j.biomaterials.2009.09.104. Epub 2009 Oct 22.
2
Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.鼻腔接种用 N-三甲基壳聚糖和 PLGA 基纳米粒:纳米粒特性决定了包封抗原在小鼠体内的抗体应答的质量和强度。
Vaccine. 2010 Aug 31;28(38):6282-91. doi: 10.1016/j.vaccine.2010.06.121. Epub 2010 Jul 16.
3
The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting.肝素或壳聚糖偶联的普朗尼克修饰的 PLGA 纳米粒的表面功能化对肿瘤靶向的影响。
J Control Release. 2010 May 10;143(3):374-82. doi: 10.1016/j.jconrel.2010.01.017. Epub 2010 Jan 25.
4
Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor.壳聚糖修饰的聚乳酸-羟基乙酸共聚物纳米颗粒与肿瘤之间增强的静电相互作用。
Int J Pharm. 2009 Apr 17;371(1-2):142-7. doi: 10.1016/j.ijpharm.2008.12.007. Epub 2008 Dec 11.
5
Enhanced surface attachment of protein-type targeting ligands to poly(lactide-co-glycolide) nanoparticles using variable expression of polymeric acid functionality.利用聚合物酸功能的可变表达增强蛋白质型靶向配体与聚(丙交酯-共-乙交酯)纳米颗粒的表面附着。
J Biomed Mater Res A. 2008 Dec 15;87(4):873-84. doi: 10.1002/jbm.a.31835.
6
Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123.靶向中枢神经系统:载有洛哌丁胺和罗丹明-123的肽衍生纳米颗粒的体内实验
J Control Release. 2007 Sep 11;122(1):1-9. doi: 10.1016/j.jconrel.2007.05.022. Epub 2007 May 26.
7
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution.唾液酸和糖肽偶联的 PLGA 纳米粒用于中枢神经系统靶向:体内药代动力学证据和生物分布。
J Control Release. 2010 Jul 1;145(1):49-57. doi: 10.1016/j.jconrel.2010.03.008. Epub 2010 Mar 23.
8
Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.透明质酸锚定的阿霉素聚乳酸-羟基乙酸共聚物纳米颗粒载体的研制与表征
Nanomedicine. 2007 Dec;3(4):246-57. doi: 10.1016/j.nano.2007.09.004.
9
Brain targeting with surface-modified poly(D,L-lactic-co-glycolic acid) nanoparticles delivered via carotid artery administration.经颈动脉给药的表面修饰聚(D,L-乳酸-共-乙醇酸)纳米粒脑靶向给药。
Eur J Pharm Biopharm. 2011 Jan;77(1):84-8. doi: 10.1016/j.ejpb.2010.11.002. Epub 2010 Nov 11.
10
Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.壳聚糖修饰的聚(D,L-乳酸-共-乙醇酸)纳米球用于质粒 DNA 递送和 HBV 基因沉默。
Int J Pharm. 2011 Aug 30;415(1-2):259-66. doi: 10.1016/j.ijpharm.2011.05.053. Epub 2011 May 27.

引用本文的文献

1
Nanoparticle‑based delivery systems for targeted therapy in brain tumors: Progress, challenges and perspectives (Review).基于纳米颗粒的脑肿瘤靶向治疗递送系统:进展、挑战与展望(综述)
Int J Oncol. 2025 Oct;67(4). doi: 10.3892/ijo.2025.5789. Epub 2025 Aug 24.
2
Nanotechnology in Parkinson's Disease: overcoming drug delivery challenges and enhancing therapeutic outcomes.帕金森病中的纳米技术:克服药物递送挑战并提高治疗效果。
Drug Deliv Transl Res. 2025 Jan 29. doi: 10.1007/s13346-025-01799-8.
3
Folate-engineered chitosan nanoparticles: next-generation anticancer nanocarriers.
叶酸修饰壳聚糖纳米粒:新一代抗癌纳米载体。
Mol Cancer. 2024 Oct 31;23(1):244. doi: 10.1186/s12943-024-02163-z.
4
Poly(lactic-co-glycolic acid) nanoparticle fabrication, functionalization, and biological considerations for drug delivery.聚(乳酸-乙醇酸)纳米颗粒的制备、功能化及药物递送的生物学考量
Biomicrofluidics. 2024 Sep 17;18(5):051503. doi: 10.1063/5.0201465. eCollection 2024 Sep.
5
Nanomaterials that Aid in the Diagnosis and Treatment of Alzheimer's Disease, Resolving Blood-Brain Barrier Crossing Ability.有助于阿尔茨海默病诊断和治疗的纳米材料,解决血脑屏障穿透能力问题。
Adv Sci (Weinh). 2024 Oct;11(38):e2403473. doi: 10.1002/advs.202403473. Epub 2024 Aug 5.
6
Receptor-Assisted Nanotherapeutics for Overcoming the Blood-Brain Barrier.受体介导的纳米治疗克服血脑屏障。
Mol Neurobiol. 2024 Nov;61(11):8702-8738. doi: 10.1007/s12035-024-04015-9. Epub 2024 Apr 1.
7
Biomembrane-Derived Nanoparticles in Alzheimer's Disease Therapy: A Comprehensive Review of Synthetic Lipid Nanoparticles and Natural Cell-Derived Vesicles.生物膜衍生纳米颗粒在阿尔茨海默病治疗中的应用:合成脂质纳米颗粒和天然细胞衍生囊泡的综合评价。
Int J Nanomedicine. 2023 Dec 7;18:7441-7468. doi: 10.2147/IJN.S436774. eCollection 2023.
8
Adverse Effects of Non-Metallic Nanoparticles in the Central Nervous System.非金属纳米颗粒对中枢神经系统的不良影响
Materials (Basel). 2023 Nov 21;16(23):7264. doi: 10.3390/ma16237264.
9
A Promising Approach: Magnetic Nanosystems for Alzheimer's Disease Theranostics.一种有前景的方法:用于阿尔茨海默病诊疗的磁性纳米系统。
Pharmaceutics. 2023 Sep 13;15(9):2316. doi: 10.3390/pharmaceutics15092316.
10
One Pot Synthesis, Biological Efficacy of AuNPs and Au-Amoxicillin Conjugates Functionalized with Crude Flavonoids Extract of .一锅法合成、AuNPs 及 Au-阿莫西林缀合物的生物功效,该缀合物功能化于 的粗黄酮提取物
Molecules. 2023 Apr 9;28(8):3320. doi: 10.3390/molecules28083320.